Clinical Trials Logo

H. Pylori Infection clinical trials

View clinical trials related to H. Pylori Infection.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06425393 Not yet recruiting - H.Pylori Infection Clinical Trials

Intrafamilial Helicobacter Pylori Infection in Hong Kong

Start date: June 11, 2024
Phase: N/A
Study type: Interventional

It is a single-centre, prospective cohort study, which will be conducted in a tertiary academic hospital. The study aims to investigate intrafamilial H. pylori infection status and to identify risk factors for H. pylori infection among household members. The rate of intrafamilial H. pylori spread in Hong Kong is currently unknown. It is also not clear whether the same risk factors for intrafamilial spread of H. pylori infection also apply in Hong Kong. In contrast to mainland China and Taiwan , recent consensus guideline on H. pylori management in Hong Kong in 2023 recommends against routine testing of asymptomatic household members or family members of H. pylori-infected adults. There is a knowledge gap on whether the family-based H. pylori screening is cost effective in our locality. Thus, the investigator aim to investigate infection status of household members of H. pylori infected individuals and risk factors for household infection in Hong Kong. The result from this study will shed light on the role of family-based screening and can inform future healthcare policy making on the strategy of H. pylori management and treatment in Hong Kong, ameliorating H. pylori infection-related disease and gastric cancer burden for society.

NCT ID: NCT06412640 Not yet recruiting - H. Pylori Infection Clinical Trials

Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori

Start date: June 1, 2024
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of keverprazan with different doses of amoxicillin for Helicobacter Pylori.

NCT ID: NCT06176547 Not yet recruiting - H.Pylori Infection Clinical Trials

Relation of Helicobacter Pylori in Prediabetic Patients

Start date: March 1, 2024
Phase:
Study type: Observational

The primary objective of this study is to : find the relation between H.pylori infection and pre-diabetic patients with lipid profile . Specifically, the study aims to: 1. affect of H.pylori infection in pre-diabetic patients 2. realation between Pre-diabetic patient and lipid profile 3. Risk factor of H.pylori infection in pre-diabetic patients D)HbA1C test measures your average blood sugar level over the past 2 or 3 months. e)Fasting Blood Sugar Test. f) the IgG antibody of h.pylori.

NCT ID: NCT05951998 Not yet recruiting - H.Pylori Infection Clinical Trials

Frequency of h.Pylori in Children With Dyspeptic Symptoms

Start date: August 1, 2023
Phase:
Study type: Observational

The current work aim to: Estimation of prevalence, Estimation of risk factors, Estimation of endoscopic picture of H. pylori infection in children presented with chronic or recurrent dyspeptic symptoms and/or non variceal hematemesis.

NCT ID: NCT05882968 Not yet recruiting - H.Pylori Infection Clinical Trials

Prevalence of H.Pylori in CKD Patients

Start date: July 1, 2023
Phase:
Study type: Observational

The study aims to:- - Investigate the relationship between H. pylori and CKD, in order to determine whether an association exists between H.pylori and kidneys.

NCT ID: NCT05789550 Not yet recruiting - H Pylori Infection Clinical Trials

HELICOBACTER PYLORI INFECTION IN TYPE 2 DIABETES MELLITUS IN ASSIUT UNIVERSITY HOSPITAL

Start date: April 1, 2023
Phase:
Study type: Observational

The aim is to study the association of H. pylori infection with T2DM and its relation with glycated hemoglobin (HbA1c) levels

NCT ID: NCT05444439 Not yet recruiting - H Pylori Infection Clinical Trials

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

Start date: September 2022
Phase: N/A
Study type: Interventional

- Detection of primary antimicrobial susceptibility and resistance of Helicobacter Pylori infection. - Detection of resistance and virulence genes of Helicobacter Pylori infection. - Assessment of H pylori carcinogenicity gene. - Evaluation of outcome and efficacy of antibiotics regimen will be used in our research. - Evaluation of effect of other factors as diet (fatty and spicy meal), drugs as NSAIDs use, antibiotics for any cause on response of H pylori to antibiotics regimen.

NCT ID: NCT05387005 Not yet recruiting - H. Pylori Infection Clinical Trials

Screening Strategy for Gastric Cancer Prevention

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

There are still some unsolved questions regarding population-based screening program for H. pylori infection to prevent gastric cancer, such as how to perform the optimal screening strategies. A prospective, randomized trial will be conducted to compare the acceptability, compliance (/adherence), and accuracy of diagnostic tests in a population-based H. pylori screening and gastric cancer prevention program. The investigators will recruit 10,000 adults with age of ≥20 years who have not received H. pylori screening or treatment. Eligible patients will be randomly 1:1:1:1 allocated to four groups with different combination tests.

NCT ID: NCT04550858 Not yet recruiting - H.Pylori Infection Clinical Trials

h.Pylori Ttt With Rebamipide

Start date: September 5, 2020
Phase:
Study type: Observational

the primary aim is specially in resistant cases of H.pylori and in promotion of peptic ulcer

NCT ID: NCT03911791 Not yet recruiting - H Pylori Infection Clinical Trials

Screening of Helicobacter Pylori in Children of Positive Infected Mothers

Start date: April 1, 2020
Phase:
Study type: Observational

Helicobacter pylori is aspiral shaped gram negative organism that colonized the gastric mucosa.it was showen that intra familial infection play role in transmission of H pylori and mother play the key role in transmission .